SE445422B - Farmaceutisk beredning for oral administereing innehallande 8-metoxi-furo-/3',2':6,7/-kumarin - Google Patents

Farmaceutisk beredning for oral administereing innehallande 8-metoxi-furo-/3',2':6,7/-kumarin

Info

Publication number
SE445422B
SE445422B SE8004383A SE8004383A SE445422B SE 445422 B SE445422 B SE 445422B SE 8004383 A SE8004383 A SE 8004383A SE 8004383 A SE8004383 A SE 8004383A SE 445422 B SE445422 B SE 445422B
Authority
SE
Sweden
Prior art keywords
resp
active substance
capsules
oral administration
pharmaceutical preparation
Prior art date
Application number
SE8004383A
Other languages
English (en)
Swedish (sv)
Other versions
SE8004383L (sv
Inventor
L H Schlager
Original Assignee
Gerot Pharmazeutika
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AT444979A external-priority patent/AT361116B/de
Priority claimed from AT0221080A external-priority patent/AT366573B/de
Application filed by Gerot Pharmazeutika filed Critical Gerot Pharmazeutika
Publication of SE8004383L publication Critical patent/SE8004383L/xx
Publication of SE445422B publication Critical patent/SE445422B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
SE8004383A 1979-06-25 1980-06-12 Farmaceutisk beredning for oral administereing innehallande 8-metoxi-furo-/3',2':6,7/-kumarin SE445422B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT444979A AT361116B (de) 1979-06-25 1979-06-25 Verfahren zur herstellung einer pharma- zeutischen zubereitung zur oralen verabreichung
AT0221080A AT366573B (de) 1980-04-24 1980-04-24 Verfahren zur herstellung einer pharmazeutischen zubereitung

Publications (2)

Publication Number Publication Date
SE8004383L SE8004383L (sv) 1980-12-26
SE445422B true SE445422B (sv) 1986-06-23

Family

ID=25597954

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8004383A SE445422B (sv) 1979-06-25 1980-06-12 Farmaceutisk beredning for oral administereing innehallande 8-metoxi-furo-/3',2':6,7/-kumarin

Country Status (7)

Country Link
US (1) US4913901A (de)
DE (1) DE3023109A1 (de)
FI (1) FI72428C (de)
FR (1) FR2459658A1 (de)
GB (1) GB2052980B (de)
NO (1) NO153951C (de)
SE (1) SE445422B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1173751A (en) * 1980-05-07 1984-09-04 Jack H. Lazarus Methoxsalen dosage forms
EP0172893A4 (de) * 1984-03-01 1987-05-13 John Royle Casley-Smith Behandlung von ödemen mit hohem proteingehalt bei tieren.
EP0174958B1 (de) * 1984-03-01 1991-12-18 Lamorna Investments Proprietary Limited Behandlung von ödemen mit hohem proteingehalt durch direktes aufbringen von benzopyronen
LU85829A1 (fr) * 1985-04-01 1986-11-05 Cird Composition pour bains a base de psoralene dans le traitement du psoriasis
US4999375A (en) * 1989-04-11 1991-03-12 Hoffmann-La Roche Inc. Psoralen reagent compositions for extracorporeal treatment of blood
GB2318291B (en) * 1996-10-15 1998-09-23 Robin Morley 8-Methoxypsoralen containing additives for topical application in bath water
CN1189175C (zh) * 1998-10-08 2005-02-16 高新研究公司 用于预防和治疗原虫病的组合物和方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2406444A1 (fr) * 1977-10-21 1979-05-18 Goupil Jean Jacques Nouveau medicament contenant un derive du psoralene
US4130568A (en) * 1976-09-14 1978-12-19 Hoffmann-La Roche Inc. 8-Methoxypsoralen derivatives
US4454152A (en) * 1980-05-07 1984-06-12 Hoffmann-La Roche Inc. Methoxsalen dosage forms

Also Published As

Publication number Publication date
SE8004383L (sv) 1980-12-26
FR2459658B1 (de) 1984-04-27
NO153951B (no) 1986-03-17
NO801759L (no) 1980-12-29
NO153951C (no) 1986-06-25
GB2052980B (en) 1983-12-14
FI72428C (fi) 1987-06-08
FI72428B (fi) 1987-02-27
US4913901A (en) 1990-04-03
FI801988A (fi) 1980-12-26
DE3023109A1 (de) 1981-01-08
FR2459658A1 (fr) 1981-01-16
GB2052980A (en) 1981-02-04

Similar Documents

Publication Publication Date Title
TWI311464B (en) Antifungal composition with enhanced bioavailability
US5583105A (en) Oral pharmaceutical preparation
EA013744B1 (ru) Фармацевтические композиции на основе нейроактивного стероида и их применение
SE455671B (sv) Flytande farmaceutisk komposition for nasal administration innefattande en kalcitonin och bensalkoniumklorid samt behallare for denna komposition
KR20060123728A (ko) 페노피브레이트를 함유하는 약학적 조성물 및 이들의 제조방법
SE445422B (sv) Farmaceutisk beredning for oral administereing innehallande 8-metoxi-furo-/3',2':6,7/-kumarin
AU2018204334A1 (en) Improved daptomycin injectable formulation
Wu et al. Microemulsions vs chitosan derivative-coated microemulsions for dermal delivery of 8-methoxypsoralen
Grießmann et al. Dosing accuracy of measuring devices provided with antibiotic oral suspensions
CN106132204A (zh) 西地那非溶液和其制备和使用方法
Thompson et al. Testing of Fat Emulsions for Toxicity: III. Toxicity Studies with New Fat Emulsions and Emulsion Components
CN101961426B (zh) 普洱茶的提取物及提取方法
CN101416939B (zh) 葛根素液体制剂及其制备方法
Santoveña et al. Study of quality and stability of ursodeoxycholic acid formulations for oral pediatric administration
WO2000053212A1 (fr) Composition pharmaceutique contenant une cyclosporine
Sirtori et al. Clinical evaluation of MK‐185: A new hypolipidemic drug
Herfst et al. Influence of food on the kinetics of 8-methoxypsoralen in serum and suction blister fluid in psoriatic patients
JPH11147835A (ja) シクロスポリンを含有する新規組成物
NO318227B1 (no) Stabilisert lipofil matrise for kontrollert frigiving av aktive prinsipper, farmasoytisk sammensetning inneholdende det samme og fremgangsmate for fremstilling av disse.
Vasani et al. Preparation and evaluation of chocolate drug delivery system of albendazole
CN101439083A (zh) 具有清风热、通鼻窍的中药软胶囊剂及其制备方法和质量控制方法
KR20200111138A (ko) 용해성 및 안정성이 향상된 덱시부프로펜 시럽제제
CN112121006A (zh) 一种注射型兽用维生素ade组合物及其制备方法
Rowe et al. An international reference preparation for human serum immunoglobulin E
Mohammad et al. Efficacious formulation of anti-malarial dry suspension for pediatric use

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8004383-9

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8004383-9

Format of ref document f/p: F